Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog

Oncogene

Volumn 16, Issue 2, 1998, Pages 249-255

  Veldhoen, Nik ^a   Stewart, Jane ^b   Brown, Robert ^b   Milner, Jo ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Canine lymphoma; Canine p53 germ line mutation; Therapy induced p53 mutation

Indexed keywords

PROTEIN P53;

ANIMAL TISSUE; ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; DOG; FEMALE; GERM LINE; HETEROZYGOSITY LOSS; LYMPHOMA; MALE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALIA; CANIS FAMILIARIS;

EID: 0032518820     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201489     Document Type: Article

References (49)

1. Aas T, Børresen A-L, Geisler S, Smith-Sørensen B, Johnsen H, Varhaug JE, Akslen LA and Lønning PE. (1996). Nat. Medicine, 2, 811-814.
2. Ahuja H, Bar-Eli M, Advani SH, Benchimol S and Cline MJ. (1989). Proc. Natl. Acad. Sci. USA, 86, 6783-6787.
3. Akman SA, Doroshow JH, Burke TG and Dizdaroglu M. (1992). Biochemistry, 31, 3500-3506.
4. Bartkowiak D, Hemmer J and Röttinger E. (1992). Cancer Chemother. Pharmacol., 30, 189-192.
5. Carter RF, Valli VEO and Lumsden JH. (1986). Can. J. Vet. Res., 50, 154-164.
6. Cervantes A, Pinedo HM, Lankelma J and Schuurhuis GJ. (1988). Cancer Lett., 41, 169-177.
7. Chang H, Benchimol S, Minden MD and Messner HA. (1994). Blood, 83, 452-459.
8. Devilee P, Van Leeuwen IS, Voesten A, Rutteman GR, Vos JH and Cornelisse CJ. (1994). Anticancer Res., 14, 2039-2046.
9. Doroshow JH. (1996). Cancer Chemotherapy and Biotherapy, second edition. Chabner BA and Longo DL. (eds.) Lippincott-Raven Publ: Philadelphia, pp. 409-434.
10. el Rouby S, Thomas A, Costin D, Rosenberg CR, Potmesil M, Silber R and Newcomb EW. (1993). Blood, 82, 3452-3459.
11. Felix CA, Hosler MR, Provisor D, Salhany K, Sexsmith EA, Slater DJ, Cheung NV, Winick NJ, Strauss EA, Heyn R, Lange BJ and Malkin D. (1996). Blood, 87, 4376-4381.
12. Frebourg T, Barbier N, Yan YX, Garber JE, Dreyfus M and Fraumeni J. (1995). Amer. J. Hum. Genet., 56, 608-615.
13. Frebourg T, Kassel J, Lam KT, Gryka MA, Barbier N, Andersen TI, Borresen AL and Friend SH. (1992). Proc. Natl. Acacl. Sci. USA, 89, 6413-6417.
14. Fulton R, Forrest D, McFarlane R, Onions D and Neil JC. (1987). Nature, 326, 190-194.
15. Greenlee PG, Filippa DA, Quimby FW, Patnaik AK, Calvano SE, Matus RE, Kimmel M, Hurvitz AI and Lieberman PH. (1990). Cancer, 66, 480-490.
16. Gross-Bellard M, Oudet P and Chambon P. (1973). Eur. J. Biochem., 36, 32-38.
17. Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E, Harris CC and Montesano R. (1997). Nucleic Acids Res., 25, 151-157.
18. Harvey D and Levine AJ. (1991). Genes Dev., 5, 2375-2385.
19. Hoffmann L, Moller P, Pedersen-Bjergaard J, Waage A, Pedersen M and Hirsch FR. (1995). Ann. Oncol., 6, 781-788.
20. Hsiao MH, Yu AL, Yeargin J, Ku D and Haas M. (1994). Blood, 83, 2922-2930.
21. Kappus H. (1986). Biochem. Pharm., 35, 1-6.
22. Katz JP, Bodin ET and Coen DM. (1990). J. Virol., 64, 4288-4295.
23. Keizer HG, Pinedo HM, Schuurhuis GJ and Joenje H. (1990). Pharmac. Ther., 47, 219-231.
24. Ko LJ and Prives C. (1996). Genes and Dev., 10, 1054-1072.
25. Kraegel SA, Pazzi KA and Madewell BR. (1995). Cancer Lett., 92, 181-186.
26. Kurosawa M, Okabe M, Kunieda Y and Miyazaki T. (1994). Blood, 83, 2750-2752.
27. Lee JJ, Hughes CS, Fine RL and Page RL. (1996). Cancer, 77, 1892-1898.
28. Liu PK, Kraus E, Wu TA, Srong LC and Tainsky MA. (1996). Oncogens, 12, 2267-2278.
29. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T. (1994). Science 266, 807-810.
30. MacVean DW, Monlux AW, Anderson Jr PS, Silberg SL and Roszel JF. (1978). Ver. Path., 15, 700-715.
31. Malkin D. (1994). Biochim. Biophys. Acta, 1198, 197-213.
32. Mayr B, Schellander K, Schleger W and Reifinger M. (1994). Br. Vet. J., 150, 81-84.
33. McBride TJ, Preston BD and Loeb LA. (1991). Biochemistry, 30, 207-213.
34. Muindi J, Sinha BK, Gianni L and Myers C. (1985). Mol. Pharmac., 27, 356-365.
35. Onions DE. (1984). J Natl. Cancer Inst., 72, 909-911.
36. Pedersen-Bjergaard J, Philip P, Larsen SO, Jensen G and Byrsting K. (1990). Blood, 76, 1083-1091.
37. Pedersen-Bjergaard J, Sigsgaard TC, Nielsen D, Gjedde SB, Philip P, Hansen M, Larsen SO, Rorth M, Mouridsen H and Dombernowsky P. (1992). J. Clin. Oncol., 10, 1444-1451.
38. Preudhomme C, Lepelley P, Vachee A, Soenen V, Quesnel B, Cosson A and Fenaux P. (1993). Leukemia, 17, 1888-1890.
39. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W and Vogelstein B. (1992). Nature, 355, 846-847.
40. Soussi T, Caron de Fromental C and May P. (1990). Oncogene, 5, 945-952.
41. Southern EM. (1975). Mol. Biol., 98, 503-517.
42. Squires RA, Bush M, Melby EC, Neeley LM and Yarbrough B. (1973). J. Natl. Cancer Inst., 51, 565-572.
43. Tewey KM, Rowe TC, Yang L, Halligan BD and Liu LF. (1984). Science, 226, 466-468.
44. Turner III MJ, Everman DB, Ellington SP and Fields CE. (1990). Free Rad. Biol. Med., 9, 415-421.
45. Van Leeuwen IS, Cornelisse CJ, Misdorp W, Goedegebuure SA, Kirpensteijn J and Rutteman GR. (1997). Cancer Lett., 111, 173-178.
46. Van Leeuwen IS, Hellmen E, Cornelisse CJ, Van den Burgh B and Rutteman GR. (1996). Anticancer Res., 16, 3737-3744.
47. Varley JM, Thorncroft M, McGown G, Appleby J, Kelsey AM, Tricker KJ, Evans DGR and Birch JM. (1997). Oncogene, 14, 865-871.
48. Wada H, Asada M, Nakazawa S, Itoh H, Kobayashi Y, Inoue T, Fukumuro K, Chan LC, Sugita K, Hanada R, Akuta N, Kobayashi N and Mizutani S. (1994). Leukemia, 8, 53-59.
49. Wishart GC, Plumb JA, Going JJ, McNicol AM, McArdle CS, Tsuruo T and Kaye SB. (1990). Br. J. Cancer, 62, 758-761.